Former GSK exec resigns from Intellia board due to 'conflict'

A spokesperson for the Cambridge gene editing biotech declined to explain why Moncef Slaoui, a former top executive at GlaxoSmithKline, had left his role after just two weeks.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.